Cargando…
Long-Term Survival of a Lynch Syndrome Patient With Eight Primary Tumors: A Case Report
With the modern technological developments in the diagnosis and treatment of cancer, the survival rate of cancer patients has increased. On the other hand, the incidence of multiple primary tumors is increasing annually. Lynch syndrome (LS), an autosomal dominant disorder with germline mutations in...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128403/ https://www.ncbi.nlm.nih.gov/pubmed/35619908 http://dx.doi.org/10.3389/fonc.2022.896024 |
_version_ | 1784712553452011520 |
---|---|
author | Jiang, Jing Huang, Ting Lin, Xianlei Zhang, Yu Yang, Xuefei Huang, Ling Ye, Zhifeng Ren, Xingchang Teng, Lisong Li, Jun Kong, Mei Lian, Liyan Lu, Jinhua Zhong, Yazhen Lin, Zechen Xu, Ming Chen, Yin Lin, Shengyou |
author_facet | Jiang, Jing Huang, Ting Lin, Xianlei Zhang, Yu Yang, Xuefei Huang, Ling Ye, Zhifeng Ren, Xingchang Teng, Lisong Li, Jun Kong, Mei Lian, Liyan Lu, Jinhua Zhong, Yazhen Lin, Zechen Xu, Ming Chen, Yin Lin, Shengyou |
author_sort | Jiang, Jing |
collection | PubMed |
description | With the modern technological developments in the diagnosis and treatment of cancer, the survival rate of cancer patients has increased. On the other hand, the incidence of multiple primary tumors is increasing annually. Lynch syndrome (LS), an autosomal dominant disorder with germline mutations in DNA mismatch repair genes, increases the risk of cancer in patients carrying those mutations. In this report, we present an extremely rare case of an 81-year-old male patient with eight primary malignancies and LS. The patient is still alive having survived for more than 41 years since the initial discovery of the first tumor. The eighth and most recently diagnosed primary cancer was a malignant peripheral nerve sheath tumor. Although there have been numerous reports of malignancies in LS, malignant peripheral nerve sheath tumors have not been reported previously with LS. Here, we report, to the best of our knowledge, the first case of a malignant peripheral nerve sheath tumor with LS. |
format | Online Article Text |
id | pubmed-9128403 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91284032022-05-25 Long-Term Survival of a Lynch Syndrome Patient With Eight Primary Tumors: A Case Report Jiang, Jing Huang, Ting Lin, Xianlei Zhang, Yu Yang, Xuefei Huang, Ling Ye, Zhifeng Ren, Xingchang Teng, Lisong Li, Jun Kong, Mei Lian, Liyan Lu, Jinhua Zhong, Yazhen Lin, Zechen Xu, Ming Chen, Yin Lin, Shengyou Front Oncol Oncology With the modern technological developments in the diagnosis and treatment of cancer, the survival rate of cancer patients has increased. On the other hand, the incidence of multiple primary tumors is increasing annually. Lynch syndrome (LS), an autosomal dominant disorder with germline mutations in DNA mismatch repair genes, increases the risk of cancer in patients carrying those mutations. In this report, we present an extremely rare case of an 81-year-old male patient with eight primary malignancies and LS. The patient is still alive having survived for more than 41 years since the initial discovery of the first tumor. The eighth and most recently diagnosed primary cancer was a malignant peripheral nerve sheath tumor. Although there have been numerous reports of malignancies in LS, malignant peripheral nerve sheath tumors have not been reported previously with LS. Here, we report, to the best of our knowledge, the first case of a malignant peripheral nerve sheath tumor with LS. Frontiers Media S.A. 2022-05-10 /pmc/articles/PMC9128403/ /pubmed/35619908 http://dx.doi.org/10.3389/fonc.2022.896024 Text en Copyright © 2022 Jiang, Huang, Lin, Zhang, Yang, Huang, Ye, Ren, Teng, Li, Kong, Lian, Lu, Zhong, Lin, Xu, Chen and Lin https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Jiang, Jing Huang, Ting Lin, Xianlei Zhang, Yu Yang, Xuefei Huang, Ling Ye, Zhifeng Ren, Xingchang Teng, Lisong Li, Jun Kong, Mei Lian, Liyan Lu, Jinhua Zhong, Yazhen Lin, Zechen Xu, Ming Chen, Yin Lin, Shengyou Long-Term Survival of a Lynch Syndrome Patient With Eight Primary Tumors: A Case Report |
title | Long-Term Survival of a Lynch Syndrome Patient With Eight Primary Tumors: A Case Report |
title_full | Long-Term Survival of a Lynch Syndrome Patient With Eight Primary Tumors: A Case Report |
title_fullStr | Long-Term Survival of a Lynch Syndrome Patient With Eight Primary Tumors: A Case Report |
title_full_unstemmed | Long-Term Survival of a Lynch Syndrome Patient With Eight Primary Tumors: A Case Report |
title_short | Long-Term Survival of a Lynch Syndrome Patient With Eight Primary Tumors: A Case Report |
title_sort | long-term survival of a lynch syndrome patient with eight primary tumors: a case report |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128403/ https://www.ncbi.nlm.nih.gov/pubmed/35619908 http://dx.doi.org/10.3389/fonc.2022.896024 |
work_keys_str_mv | AT jiangjing longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport AT huangting longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport AT linxianlei longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport AT zhangyu longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport AT yangxuefei longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport AT huangling longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport AT yezhifeng longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport AT renxingchang longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport AT tenglisong longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport AT lijun longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport AT kongmei longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport AT lianliyan longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport AT lujinhua longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport AT zhongyazhen longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport AT linzechen longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport AT xuming longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport AT chenyin longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport AT linshengyou longtermsurvivalofalynchsyndromepatientwitheightprimarytumorsacasereport |